Novavax

Rome: The European Medicines Agency (EMA) has added a fifth vaccine to its anti-Covid arsenal as the Omicron variant continued to spread across Europe. "EMA has recommended granting a conditional marketing authorisation for Novavax's…
Read More...

London: Amid calls for pushing booster doses against Covid-19 in view of the new super mutant variant Omicron that is predicted to escape vaccine immunity, a new study published in The Lancet has shown that six different Covid boosters are…
Read More...

New Delhi: The Serum Institute of India (SII) is likely to start the clinical trials of Novavax's Covid-19 vaccine on children in July. It is also planning to introduce the vaccine 'Covovax' as its version of the US firm Novavax's vaccine…
Read More...

New Delhi: US based Novavax Covid-19 vaccine candidate has demonstrated a 90.4 percent efficacy in phase 3 clinical trials. The Serum Institute of India (SII), as a partner, has already started manufacturing the vaccine naming it as…
Read More...

Bhubaneswar/New-Delhi : Serum Institute of India's CEO Adar Poonawalla has warned there won’t be enough Covid-19 vaccines available in the world till 2024 end. "It  will take at least four years to make enough Covid-19 vaccines for the…
Read More...

Sydney: US-based biotechnology company Novavax has started enrolling participants in Australia for a clinical trial of its coronavirus vaccine candidate, NVX-CoV2373. Preliminary immunogenicity and safety results from the Phase 1 portion…
Read More...